Jesus, der Christus des GeistesPRESS, Michael.Evangelische Theologie. 2004, Vol 64, Num 4, pp 304-314, issn 0014-3502, 11 p.Article

(Pytho)Gaia in Myth and Legend: The Goddess of the Ekron Inscription Revisited = (Pytho) Gaia dans le mythe et la légende: La déesse de l'inscription d'Ekron réétudiéePRESS, Michael D.Bulletin of the American Schools of Oriental Research. 2012, Num 365, pp 1-25, issn 0003-097X, 25 p.Article

Adjuvant Trastuzumab in HER2-Positive Breast CancerSLAMON, Dennis; EIERMANN, Wolfgang; PINTER, Tamas et al.The New England journal of medicine. 2011, Vol 365, Num 14, pp 1273-1283, issn 0028-4793, 11 p.Article

Low HER2/NEU gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancerFORMENTI, Silvia C; SPICER, Darcy; DANENBERG, Kathy et al.International journal of radiation oncology, biology, physics. 2002, Vol 52, Num 2, pp 397-405, issn 0360-3016Article

Phase III Study of Doxorubicin/Cyclophosphamide With Concomitant Versus Sequential Docetaxel As Adjuvant Treatment in Patients With Human Epidermal Growth Factor Receptor 2-Normal, Node-Positive Breast Cancer: BCIRG-005 TrialEIERMANN, Wolfgang; PIENKOWSKI, Tadeusz; PRESS, Michael et al.Journal of clinical oncology. 2011, Vol 29, Num 29, pp 3877-3884, issn 0732-183X, 8 p.Article

Impact of reproductive factors and lactation on breast carcinoma in situ riskMEESKE, Kathleen; PRESS, Michael; PATEL, Alpa et al.International journal of cancer. 2004, Vol 110, Num 1, pp 102-109, issn 0020-7136, 8 p.Article

EGFR, HER2 and VEGF pathways : Validated targets for cancer treatmentPRESS, Michael F; LENZ, Heinz-Josef.Drugs (Basel). 2007, Vol 67, Num 14, pp 2045-2075, issn 0012-6667, 31 p.Article

A Reexamination of Aegean-Style Figurines in Light of New Evidence from Ashdod, Ashkelon, and Ekron = Réexamen des figurines de style égéen à la lumière des nouveaux témoignages provenant d'Ashdod, Ashkelon et EkronBEN-SHLOMO, David; PRESS, Michael D.Bulletin of the American Schools of Oriental Research. 2009, Num 353, pp 39-74, issn 0003-097X, 36 p.Article

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab : updated efficacy and biomarker analysesCAMERON, David; CASEY, Michelle; CHAN, Arlene et al.Breast cancer research and treatment. 2008, Vol 112, Num 3, pp 533-543, issn 0167-6806, 11 p.Article

Body weight correlates with mortality in early-stage breast cancer. DiscussionENGER, Shelley M; GREIF, Jon M; POLIKOFF, Jonathan et al.Archives of surgery (Chicago, IL. 1960). 2004, Vol 139, Num 9, pp 954-960, issn 0004-0010, 7 p.Conference Paper

Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: A phase I/II trialFORMENTI, Silvia C; VOLM, Matthew; PRESS, Michael et al.Journal of clinical oncology. 2003, Vol 21, Num 5, pp 864-870, issn 0732-183X, 7 p.Article

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancerVOGEL, Charles L; COBLEIGH, Melody A; SHAK, Steven et al.Journal of clinical oncology. 2002, Vol 20, Num 3, pp 719-726, issn 0732-183XArticle

Is There a Difference in the Association between Percent Mammographic Density and Subtypes of Breast Cancer? Luminal A and Triple-Negative Breast CancerHUIYAN MA; JIANNING LUO; PRESS, Michael F et al.Cancer epidemiology, biomarkers & prevention. 2009, Vol 18, Num 2, pp 479-485, issn 1055-9965, 7 p.Article

P7 antigen expression in human breast cancerXIAOWEI YANG; GROSHEN, Susan; FORMENTI, Silvia C et al.Clinical cancer research. 2003, Vol 9, Num 1, pp 201-206, issn 1078-0432, 6 p.Article

Guidelines for Human Epidermal Growth Factor Receptor 2 Testing : Biologic and Methodologic ConsiderationsSAUTER, Guido; LEE, James; BARTLETT, John M. S et al.Journal of clinical oncology. 2009, Vol 27, Num 8, pp 1323-1333, issn 0732-183X, 11 p.Article

Lifetime recreational exercise activity and risk of breast carcinoma in situPATEL, Alpa V; PRESS, Michael F; MEESKE, Kathleen et al.Cancer. 2003, Vol 98, Num 10, pp 2161-2169, issn 0008-543X, 9 p.Article

Impact of Breast Cancer Subtypes and Treatment on Survival: An Analysis Spanning Two DecadesHAQUE, Reina; AHMED, Syed A; INZHAKOVA, Galina et al.Cancer epidemiology, biomarkers & prevention. 2012, Vol 21, Num 10, pp 1848-1855, issn 1055-9965, 8 p.Article

Germ-line HER-2 variant and breast cancer risk by stage of diseaseMCKEAN-COWDIN, Roberta; KOLONEL, Laurence N; PRESS, Michael F et al.Cancer research (Baltimore). 2001, Vol 61, Num 23, pp 8393-8394, issn 0008-5472Article

Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancerLUKAS, Jason; GAO, Da-Qing; KESHMESHIAN, Mariana et al.Cancer research (Baltimore). 2001, Vol 61, Num 7, pp 3212-3219, issn 0008-5472Article

Antibody-mediated targeting of replication-competent retroviral vectorsTAI, Chien-Kuo; LOGG, Christopher R; PARK, Jinha M et al.Human gene therapy. 2003, Vol 14, Num 8, pp 789-802, issn 1043-0342, 14 p.Article

Prognostic and Predictive Value of HER2 Extracellular Domain in Metastatic Breast Cancer Treated With Lapatinib and Paclitaxel in a Randomized Phase III StudyFINN, Richard S; GAGNON, Robert; DI LEO, Angelo et al.Journal of clinical oncology. 2009, Vol 27, Num 33, pp 5552-5558, issn 0732-183X, 7 p.Article

Evaluation of HER-2/neu gene amplification and overexpression: Comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimensPRESS, Michael F; SLAMON, Dennis J; FLOM, Kerry J et al.Journal of clinical oncology. 2002, Vol 20, Num 14, pp 3095-3105, issn 0732-183XArticle

Quantitative ER and PgR Assessment as Predictors of Benefit from Lapatinib in Postmenopausal Women with Hormone Receptor-Positive, HER2-Negative Metastatic Breast CancerFINN, Richard S; PRESS, Michael F; DERING, Judy et al.Clinical cancer research (Print). 2014, Vol 20, Num 3, pp 736-743, issn 1078-0432, 8 p.Article

Pathological characteristics of BRCA-associated breast cancers in HispanicsLAGOS-JARAMILLO, Veronica I; PRESS, Michael F; RICKER, Charite N et al.Breast cancer research and treatment. 2011, Vol 130, Num 1, pp 281-289, issn 0167-6806, 9 p.Article

Estrogen Receptor, Progesterone Receptor, Human Epidermal Growth Factor Receptor 2 (HER2), and Epidermal Growth Factor Receptor Expression and Benefit From Lapatinib in a Randomized Trial of Paclitaxel With Lapatinib or Placebo As First-Line Treatment in HER2-Negative or Unknown Metastatic Breast CancerFINN, Richard S; PRESS, Michael F; DERING, Judy et al.Journal of clinical oncology. 2009, Vol 27, Num 24, pp 3908-3915, issn 0732-183X, 8 p.Article